Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 6 of 6 entries
Sorted by: Best Match Show Resources per page
Implication of autophagy in Parkinson's disease.

Parkinson's disease

González-Polo RA, Fuentes JM, Niso-Santano M, Alvarez-Erviti L.
PMID: 23476889
Parkinsons Dis. 2013;2013:436481. doi: 10.1155/2013/436481. Epub 2013 Feb 12.

No abstract available.

Cite
González-Polo RA, Fuentes JM, Niso-Santano M, et al. Implication of autophagy in Parkinson's disease. Parkinsons Dis. 2013;2013:436481doi: 10.1155/2013/436481.
González-Polo, R. A., Fuentes, J. M., Niso-Santano, M., & Alvarez-Erviti, L. (2013). Implication of autophagy in Parkinson's disease. Parkinson's disease, 2013436481. https://doi.org/10.1155/2013/436481
González-Polo, Rosa Ana, et al. "Implication of autophagy in Parkinson's disease." Parkinson's disease vol. 2013 (2013): 436481. doi: https://doi.org/10.1155/2013/436481
González-Polo RA, Fuentes JM, Niso-Santano M, Alvarez-Erviti L. Implication of autophagy in Parkinson's disease. Parkinsons Dis. 2013;2013:436481. doi: 10.1155/2013/436481. Epub 2013 Feb 12. PMID: 23476889; PMCID: PMC3583054.
Copy Download .nbib Format: NLM
Biomonitoring of Mycotoxins in Plasma of Patients with Alzheimer's and Parkinson's Disease.

Toxins

Arce-López B, Alvarez-Erviti L, De Santis B, Izco M, López-Calvo S, Marzo-Sola ME, Debegnach F, Lizarraga E, López de Cerain A, González-Peñas E, Vettorazzi A.
PMID: 34357949
Toxins (Basel). 2021 Jul 10;13(7). doi: 10.3390/toxins13070477.

Exposure to environmental contaminants might play an important role in neurodegenerative disease pathogenesis, such as Parkinson´s disease (PD) and Alzheimer´s disease (AD). For the first time in Spain, the plasmatic levels of 19 mycotoxins from patients diagnosed with a...

Cite
Arce-López B, Alvarez-Erviti L, De Santis B, et al. Biomonitoring of Mycotoxins in Plasma of Patients with Alzheimer's and Parkinson's Disease. Toxins (Basel). 2021;13(7)doi: 10.3390/toxins13070477.
Arce-López, B., Alvarez-Erviti, L., De Santis, B., Izco, M., López-Calvo, S., Marzo-Sola, M. E., Debegnach, F., Lizarraga, E., López de Cerain, A., González-Peñas, E., & Vettorazzi, A. (2021). Biomonitoring of Mycotoxins in Plasma of Patients with Alzheimer's and Parkinson's Disease. Toxins, 13(7), . https://doi.org/10.3390/toxins13070477
Arce-López, Beatriz, et al. "Biomonitoring of Mycotoxins in Plasma of Patients with Alzheimer's and Parkinson's Disease." Toxins vol. 13,7 (2021). doi: https://doi.org/10.3390/toxins13070477
Arce-López B, Alvarez-Erviti L, De Santis B, Izco M, López-Calvo S, Marzo-Sola ME, Debegnach F, Lizarraga E, López de Cerain A, González-Peñas E, Vettorazzi A. Biomonitoring of Mycotoxins in Plasma of Patients with Alzheimer's and Parkinson's Disease. Toxins (Basel). 2021 Jul 10;13(7). doi: 10.3390/toxins13070477. PMID: 34357949; PMCID: PMC8310068.
Copy Download .nbib Format: NLM
Lack of Parkinsonian Pathology and Neurodegeneration in Mice After Long-Term Injections of a Proteasome Inhibitor in Olfactory Bulb and Amygdala.

Frontiers in aging neuroscience

Del Rey NL, Balzano T, Martin-Rodriguez L, Salinas-Rebolledo C, Trigo-Damas I, Rojas-Fernandez A, Alvarez-Erviti L, Blesa J.
PMID: 34744683
Front Aging Neurosci. 2021 Oct 21;13:698979. doi: 10.3389/fnagi.2021.698979. eCollection 2021.

Proteinaceous inclusions, called Lewy bodies (LBs), are used as a pathological hallmark for Parkinson's disease (PD). Recent studies suggested a prion-like spreading mechanism for α-synucleinopathy where early neuropathological deposits occur, among others, in the olfactory bulb (OB) and amygdala....

Cite
Del Rey NL, Balzano T, Martin-Rodriguez L, et al. Lack of Parkinsonian Pathology and Neurodegeneration in Mice After Long-Term Injections of a Proteasome Inhibitor in Olfactory Bulb and Amygdala. Front Aging Neurosci. 2021;13:698979doi: 10.3389/fnagi.2021.698979.
Del Rey, N. L., Balzano, T., Martin-Rodriguez, L., Salinas-Rebolledo, C., Trigo-Damas, I., Rojas-Fernandez, A., Alvarez-Erviti, L., & Blesa, J. (2021). Lack of Parkinsonian Pathology and Neurodegeneration in Mice After Long-Term Injections of a Proteasome Inhibitor in Olfactory Bulb and Amygdala. Frontiers in aging neuroscience, 13698979. https://doi.org/10.3389/fnagi.2021.698979
Del Rey, Natalia Lopez-Gonzalez, et al. "Lack of Parkinsonian Pathology and Neurodegeneration in Mice After Long-Term Injections of a Proteasome Inhibitor in Olfactory Bulb and Amygdala." Frontiers in aging neuroscience vol. 13 (2021): 698979. doi: https://doi.org/10.3389/fnagi.2021.698979
Del Rey NL, Balzano T, Martin-Rodriguez L, Salinas-Rebolledo C, Trigo-Damas I, Rojas-Fernandez A, Alvarez-Erviti L, Blesa J. Lack of Parkinsonian Pathology and Neurodegeneration in Mice After Long-Term Injections of a Proteasome Inhibitor in Olfactory Bulb and Amygdala. Front Aging Neurosci. 2021 Oct 21;13:698979. doi: 10.3389/fnagi.2021.698979. eCollection 2021. PMID: 34744683; PMCID: PMC8570189.
Copy Download .nbib Format: NLM
Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting.

Journal of extracellular vesicles

Wiklander OP, Nordin JZ, O'Loughlin A, Gustafsson Y, Corso G, Mäger I, Vader P, Lee Y, Sork H, Seow Y, Heldring N, Alvarez-Erviti L, Smith CI, Le Blanc K, Macchiarini P, Jungebluth P, Wood MJ, Andaloussi SE.
PMID: 25899407
J Extracell Vesicles. 2015 Apr 20;4:26316. doi: 10.3402/jev.v4.26316. eCollection 2015.

Extracellular vesicles (EVs) have emerged as important mediators of intercellular communication in a diverse range of biological processes. For future therapeutic applications and for EV biology research in general, understanding the in vivo fate of EVs is of utmost...

Cite
Wiklander OP, Nordin JZ, O'Loughlin A, et al. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J Extracell Vesicles. 2015;4:26316doi: 10.3402/jev.v4.26316.
Wiklander, O. P., Nordin, J. Z., O'Loughlin, A., Gustafsson, Y., Corso, G., Mäger, I., Vader, P., Lee, Y., Sork, H., Seow, Y., Heldring, N., Alvarez-Erviti, L., Smith, C. I., Le Blanc, K., Macchiarini, P., Jungebluth, P., Wood, M. J., & Andaloussi, S. E. (2015). Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. Journal of extracellular vesicles, 426316. https://doi.org/10.3402/jev.v4.26316
Wiklander, Oscar P B, et al. "Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting." Journal of extracellular vesicles vol. 4 (2015): 26316. doi: https://doi.org/10.3402/jev.v4.26316
Wiklander OP, Nordin JZ, O'Loughlin A, Gustafsson Y, Corso G, Mäger I, Vader P, Lee Y, Sork H, Seow Y, Heldring N, Alvarez-Erviti L, Smith CI, Le Blanc K, Macchiarini P, Jungebluth P, Wood MJ, Andaloussi SE. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J Extracell Vesicles. 2015 Apr 20;4:26316. doi: 10.3402/jev.v4.26316. eCollection 2015. PMID: 25899407; PMCID: PMC4405624.
Copy Download .nbib Format: NLM
The Two Faces of Exosomes in Parkinson's Disease: From Pathology to Therapy.

The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry

Izco M, Carlos E, Alvarez-Erviti L.
PMID: 33530851
Neuroscientist. 2021 Feb 03;1073858421990001. doi: 10.1177/1073858421990001. Epub 2021 Feb 03.

Accumulating evidence suggests that exosomes play a key role in Parkinson's disease (PD). Exosomes may contribute to the PD progression facilitating the spread of pathological alpha-synuclein or activating immune cells. Glial cells also release exosomes, and transmission of exosomes...

Cite
Izco M, Carlos E, Alvarez-Erviti L. The Two Faces of Exosomes in Parkinson's Disease: From Pathology to Therapy. Neuroscientist. 2021;1073858421990001doi: 10.1177/1073858421990001.
Izco, M., Carlos, E., & Alvarez-Erviti, L. (2021). The Two Faces of Exosomes in Parkinson's Disease: From Pathology to Therapy. The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry, 1073858421990001. https://doi.org/10.1177/1073858421990001
Izco, Maria, et al. "The Two Faces of Exosomes in Parkinson's Disease: From Pathology to Therapy." The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry vol. (2021): 1073858421990001. doi: https://doi.org/10.1177/1073858421990001
Izco M, Carlos E, Alvarez-Erviti L. The Two Faces of Exosomes in Parkinson's Disease: From Pathology to Therapy. Neuroscientist. 2021 Feb 03;1073858421990001. doi: 10.1177/1073858421990001. Epub 2021 Feb 03. PMID: 33530851.
Copy Download .nbib Format: NLM
DJ-1 is a redox sensitive adapter protein for high molecular weight complexes involved in regulation of catecholamine homeostasis.

Human molecular genetics

Piston D, Alvarez-Erviti L, Bansal V, Gargano D, Yao Z, Szabadkai G, Odell M, Puno MR, Björkblom B, Maple-Grødem J, Breuer P, Kaut O, Larsen JP, Bonn S, Møller SG, Wüllner U, Schapira AHV, Gegg ME.
PMID: 29309579
Hum Mol Genet. 2018 Feb 01;27(3):576. doi: 10.1093/hmg/ddx425.

No abstract available.

Cite
Piston D, Alvarez-Erviti L, Bansal V, et al. DJ-1 is a redox sensitive adapter protein for high molecular weight complexes involved in regulation of catecholamine homeostasis. Hum Mol Genet. 2018;27(3):576doi: 10.1093/hmg/ddx425.
Piston, D., Alvarez-Erviti, L., Bansal, V., Gargano, D., Yao, Z., Szabadkai, G., Odell, M., Puno, M. R., Björkblom, B., Maple-Grødem, J., Breuer, P., Kaut, O., Larsen, J. P., Bonn, S., Møller, S. G., Wüllner, U., Schapira, A. H. V., & Gegg, M. E. (2018). DJ-1 is a redox sensitive adapter protein for high molecular weight complexes involved in regulation of catecholamine homeostasis. Human molecular genetics, 27(3), 576. https://doi.org/10.1093/hmg/ddx425
Piston, Dominik, et al. "DJ-1 is a redox sensitive adapter protein for high molecular weight complexes involved in regulation of catecholamine homeostasis." Human molecular genetics vol. 27,3 (2018): 576. doi: https://doi.org/10.1093/hmg/ddx425
Piston D, Alvarez-Erviti L, Bansal V, Gargano D, Yao Z, Szabadkai G, Odell M, Puno MR, Björkblom B, Maple-Grødem J, Breuer P, Kaut O, Larsen JP, Bonn S, Møller SG, Wüllner U, Schapira AHV, Gegg ME. DJ-1 is a redox sensitive adapter protein for high molecular weight complexes involved in regulation of catecholamine homeostasis. Hum Mol Genet. 2018 Feb 01;27(3):576. doi: 10.1093/hmg/ddx425. PMID: 29309579; PMCID: PMC5886203.
Copy Download .nbib Format: NLM
Showing 1 to 6 of 6 entries